NASHVILLE, Tenn. / Jun 30, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 2Q 2025 Earnings Call | |
When: | Friday, July 25, 2025 at 9:00 AM Central (10:00 AM Eastern) | |
How: | Live Audio over the Internet: | |
https://investor.hcahealthcare.com/events-and-presentations/default.aspx | ||
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$404.94 |
| Daily Change: | 2.98 0.74 |
| Daily Volume: | 150,971 |
| Market Cap: | US$94.750B |
July 25, 2025 April 25, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
